Improving access to care and services
We collaborate with public and private sector organizations to expand access to care and services to improve global health.
Featured stories
-
-
Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
Sub-Saharan African Ministries of Health Invited to Submit Expression of Interest to Participate in New EffortDonation Program to be Part of Broader Initiative to Raise Awareness and Action
-
-
Johnson & Johnson secures a top spot on the 2016 Access to Medicine Index
The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.
More from Johnson & Johnson
-
Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health
Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 26 years since it entered the market, this groundbreaking device has helped more than 450,000 patients recover from heart injuries. -
Johnson & Johnson’s ICOTYDE® (icotrokinra) named to Time’s Best Inventions of 2026 list
The first-of-its-kind targeted oral peptide therapy for moderate to severe plaque psoriasis has been chosen for the annual list, which recognizes innovations for their originality, ambition and impact. -
What you need to know about Johnson & Johnson’s third-quarter 2026 earnings report
Check out this infographic breakdown of the company’s third-quarter performance, with highlights from its Innovative Medicine and MedTech businesses.
